Carbon monoxide suppresses membrane expression of TLR4 via myeloid differentiation factor-2 in βTC3 cells

Journal of Immunology

Volumn 185, Issue 4, 2010, Pages 2134-2139

  Rocuts, Fredy ^a   Ma, Yinghua ^b   Zhang, Xinyu ^a   Gao, Wenda ^a   Yue, Yinan ^a   Vartanian, Timothy ^b   Wang, Hongjun ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; CARBON MONOXIDE; MYELOID DIFFERENTIATION FACTOR 2 PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUNICAMYCIN; UNCLASSIFIED DRUG; ANTIMETABOLITE; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION PROTEIN 2, MOUSE; MYELOID DIFFERENTIATION PROTEIN-2, MOUSE; PHOTOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YELLOW FLUORESCENT PROTEIN, MOUSE;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENETIC TRANSFECTION; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INSULINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; ANIMAL; CELL MEMBRANE; DRUG EFFECT; GENETICS; METABOLISM; PROTEIN TRANSPORT; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIMETABOLITES; BLOTTING, WESTERN; CARBON MONOXIDE; CELL LINE, TUMOR; CELL MEMBRANE; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; LIPOPOLYSACCHARIDES; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; RNA INTERFERENCE; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 77956942676     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902782     Document Type: Article

References (41)

1. Cristofaro, P., and S. M. Opal. 2006. Role of Toll-like receptors in infection and immunity: clinical implications. Drugs 66: 15-29.
2. Uematsu, S., and S. Akira. 2007. Toll-like receptors and Type I interferons. J. Biol. Chem. 282: 15319-15323.
3. Shi, Z., Z. Cai, S. Wen, C. Chen, C. Gendron, A. Sanchez, K. Patterson, S. Fu, J. Yang, D. E. Wildman, et al. 2009. Transcriptional regulation of the novel Toll-like receptor Tlr13. J. Biol. Chem. 284: 20540-20547.
4. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
5. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
6. Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr, P. F. Mühlradt, and S. Akira. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164: 554-557. (Pubitemid 30043671)
7. Takeuchi, O., K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, and S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12: 113-117.
8. Pålsson-McDermott, E. M., and L. A. O'Neill. 2004. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162.
9. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/ TLR4-specific antiviral gene program. Immunity 17: 251-263. (Pubitemid 35279547)
10. Verstak, B., K. Nagpal, S. P. Bottomley, D. T. Golenbock, P. J. Hertzog, and A. Mansell. 2009. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J. Biol. Chem. 284: 24192-24203.
11. Aksoy, E., W. Vanden Berghe, S. Detienne, Z. Amraoui, K. A. Fitzgerald, G. Haegeman, M. Goldman, and F.Willems. 2005. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Eur. J. Immunol. 35: 2200-2209.
12. O'Neill, L. A., K. A. Fitzgerald, and A. G. Bowie. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286-290.
13. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat. Immunol. 9: 361-368.
14. Wang, H., S. S. Lee, W. Gao, E. Czismadia, J. McDaid, R. Ollinger, M. P. Soares, K. Yamashita, and F. H. Bach. 2005. Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 54: 1400-1406.
15. Goldberg, A., M. Parolini, B. Y. Chin, E. Czismadia, L. E. Otterbein, F. H. Bach, and H. Wang. 2007. Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J. 21: 2840-2848.
16. Ohnishi, T., M. Muroi, and K. Tanamoto. 2003. MD-2 is necessary for the Tolllike receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 10: 405-410.
17. Nagai, Y., S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto, and K. Miyake. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3: 667-672.
18. Fujimoto, T., S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta. 2004. The amino-terminal region of Toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279: 47431-47437.
19. Saitoh, S., and K. Miyake. 2006. Mechanism regulating cell surface expression and activation of Toll-like receptor 4. Chem. Rec. 6: 311-319.
20. Wakabayashi, Y., M. Kobayashi, S. Akashi-Takamura, N. Tanimura, K. Konno, K. Takahashi, T. Ishii, T. Mizutani, H. Iba, T. Kouro, et al. 2006. A protein associated with Toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J. Immunol. 177: 1772-1779. (Pubitemid 44092514)
21. Kiyokawa, T., S. Akashi-Takamura, T. Shibata, F. Matsumoto, C. Nishitani, Y. Kuroki, Y. Seto, and K. Miyake. 2008. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors. Int. Immunol. 20: 1407-1415.
22. Takahashi, K., T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, et al. 2007. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J. Exp. Med. 204: 2963-2976.
23. Nakahira, K., H. P. Kim, X. H. Geng, A. Nakao, X. Wang, N. Murase, P. F. Drain, X. Wang, M. Sasidhar, E. G. Nabel, et al. 2006. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced traf- ficking of TLRs to lipid rafts. J. Exp. Med. 203: 2377-2389.
24. Wang, X. M., H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. Choi. 2009. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 182: 3809-3818.
25. Vink, A., A. H. Schoneveld, J. J. van der Meer, B. J. van Middelaar, J. P. Sluijter, M. B. Smeets, P. H. Quax, S. K. Lim, C. Borst, G. Pasterkamp, and D. P. de Kleijn. 2002. In vivo evidence for a role of Toll-like receptor 4 in the development of intimal lesions. Circulation 106: 1985-1990.
26. Hollestelle, S. C., M. R. De Vries, J. K. Van Keulen, A. H. Schoneveld, A. Vink, C. F. Strijder, B. J. Van Middelaar, G. Pasterkamp, P. H. Quax, and D. P. De Kleijn. 2004. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109: 393-398.
27. Methe, H., E. Zimmer, C. Grimm, M. Nabauer, and J. Koglin. 2004. Evidence for a role of Toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 78: 1324-1331.
28. Zhai, Y., X. D. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173: 7115-7119.
29. Kaczorowski, D. J., A. Nakao, R. Vallabhaneni, K. P. Mollen, R. Sugimoto, J. Kohmoto, B. S. Zuckerbraun, K. R. McCurry, and T. R. Billiar. 2009. Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87: 1455-1463.
30. Kaczorowski, D. J., A. Nakao, K. P. Mollen, R. Vallabhaneni, R. Sugimoto, J. Kohmoto, K. Tobita, B. S. Zuckerbraun, K. R. McCurry, N. Murase, and T. R. Billiar. 2007. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84: 1279-1287.
31. Lien, E., and D. Zipris. 2009. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 9: 52-68.
32. Devaraj, S., M. R. Dasu, J. Rockwood, W. Winter, S. C. Griffen, and I. Jialal. 2008. Increased Toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J. Clin. Endocrinol. Metab. 93: 578-583.
33. Devaraj, S., M. R. Dasu, S. H. Park, and I. Jialal. 2009. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52: 1665-1668.
34. Zhai, Y., B. Qiao, X. D. Shen, F. Gao, R. W. Busuttil, G. Cheng, J. L. Platt, H. D. Volk, and J. W. Kupiec-Weglinski. 2008. Evidence for the pivotal role of endogenous Toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 85: 1016-1022.
35. Racke, M. K., W. Hu, and A. E. Lovett-Racke. 2005. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 26: 289-291.
36. Nichols, B. J., A. K. Kenworthy, R. S. Polishchuk, R. Lodge, T. H. Roberts, K. Hirschberg, R. D. Phair, and J. Lippincott-Schwartz. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153: 529-541.
37. Viriyakosol, S., P. S. Tobias, R. L. Kitchens, and T. N. Kirkland. 2001. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276: 38044-38051.
38. Nagai, Y., R. Shimazu, H. Ogata, S. Akashi, K. Sudo, H. Yamasaki, S. Hayashi, Y. Iwakura, M. Kimoto, and K. Miyake. 2002. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99: 1699-1705.
39. Akashi, S., R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, and K. Miyake. 2000. Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164: 3471-3475.
40. Kataoka, H., M. Yasuda, M. Iyori, K. Kiura, M. Narita, T. Nakata, and K. Shibata. 2006. Roles of N-linked glycans in the recognition of microbial lipopeptides and lipoproteins by TLR2. Cell. Microbiol. 8: 1199-1209.
41. Weber, A. N., M. A. Morse, and N. J. Gay. 2004. Four N-linked glycosylation sites in human Toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J. Biol. Chem. 279: 34589-34594.